3
Participants
Start Date
November 28, 2019
Primary Completion Date
December 31, 2024
Study Completion Date
March 11, 2025
Carglumic Acid (Carbaglu®)
"A. Study period: 36 months; treatment period: 12 months.~B. Patients will receive Carglumic Acid (Carbaglu®) 50 mg/kg/day in addition to standard therapy (protein restricted diet, L-carnitine, metronidazole and vitamin B12).~C. Patients need to regularly come back for follow up examination on Day 0, month 3, month 6, and month 12.~D. Patients should report any adverse event that occur during treatment period.~E. Patients' number of emergency visits due to hyperammonemia, ammonia level, acylcarnitine, urinary organic acid analysis, plasma amino acid analysis and methylmalonic acid will be recorded during treatment period."
National Taiwan University Hospital, Taipei
National Taiwan University Hospital
OTHER